• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel.

Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel. Biol Blood Marrow Transplant. 2003 Jun; 9(6):364-72.

View in: PubMed

subject areas
  • Acute Disease
  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Bone Marrow Cells
  • Bone Marrow Purging
  • Colony-Forming Units Assay
  • Dose-Response Relationship, Drug
  • Hematopoietic Stem Cells
  • HL-60 Cells
  • Humans
  • Immunotoxins
  • In Vitro Techniques
  • Leukemia, Myeloid
  • Models, Biological
  • Plant Proteins
  • Recombinant Proteins
  • Ribosome Inactivating Proteins, Type 1
  • Sialic Acid Binding Ig-like Lectin 3
  • Tumor Stem Cell Assay

authors with profiles
  • Armand B. Glassman